These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35398731)

  • 1. Novel niclosamide-derived adjuvants elevating the efficacy of polymyxin B against MDR Pseudomonas aeruginosa DK2.
    Lu T; Zheng X; Mao F; Cao Q; Cao Q; Zhu J; Li X; Lan L; Li B; Li J
    Eur J Med Chem; 2022 Jun; 236():114318. PubMed ID: 35398731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa.
    Qi L; Liang R; Duan J; Song S; Pan Y; Liu H; Zhu M; Li L
    J Antibiot (Tokyo); 2022 Oct; 75(10):567-575. PubMed ID: 35999263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.
    Berditsch M; Jäger T; Strempel N; Schwartz T; Overhage J; Ulrich AS
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5288-96. PubMed ID: 26077259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
    Tam VH; Schilling AN; Vo G; Kabbara S; Kwa AL; Wiederhold NP; Lewis RE
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3624-30. PubMed ID: 16127031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by
    Salman M; Rizwana R; Khan H; Munir I; Hamayun M; Iqbal A; Rehman A; Amin K; Ahmed G; Khan M; Khan A; Amin FU
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2465-2472. PubMed ID: 31187657
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy.
    Gorityala BK; Guchhait G; Fernando DM; Deo S; McKenna SA; Zhanel GG; Kumar A; Schweizer F
    Angew Chem Int Ed Engl; 2016 Jan; 55(2):555-9. PubMed ID: 26610184
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chen H; Li H; Liu Z; Li J
    Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Conery AL; Kim W; Jayamani E; Kwon B; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(4):e0124595. PubMed ID: 25897961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing.
    Imperi F; Massai F; Ramachandran Pillai C; Longo F; Zennaro E; Rampioni G; Visca P; Leoni L
    Antimicrob Agents Chemother; 2013 Feb; 57(2):996-1005. PubMed ID: 23254430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Action and Resistance Evasion of an Antimicrobial Oligomer against Multidrug-Resistant Gram-Negative Bacteria.
    O'Leary MK; Sundaram V; LiPuma JJ; Dörr T; Westblade LF; Alabi CA
    ACS Appl Bio Mater; 2022 Mar; 5(3):1159-1168. PubMed ID: 35167257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments.
    Olsson A; Wistrand-Yuen P; Nielsen EI; Friberg LE; Sandegren L; Lagerbäck P; Tängdén T
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.